KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Bionano Genomics (BNGO) Other Gross PP&E Adjustments (2017 - 2025)

Bionano Genomics' Other Gross PP&E Adjustments history spans 7 years, with the latest figure at -$3.1 million for Q3 2025.

  • For Q3 2025, Other Gross PP&E Adjustments fell 1250.21% year-over-year to -$3.1 million; the TTM value through Sep 2025 reached -$3.1 million, down 1250.21%, while the annual FY2024 figure was $42.1 million, 21.1% up from the prior year.
  • Other Gross PP&E Adjustments for Q3 2025 was -$3.1 million at Bionano Genomics, up from -$3.2 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $42.1 million in Q4 2024 and bottomed at -$7.1 million in Q1 2023.
  • The 5-year median for Other Gross PP&E Adjustments is -$3.4 million (2023), against an average of $4.0 million.
  • The largest annual shift saw Other Gross PP&E Adjustments soared 93.45% in 2024 before it plummeted 1250.21% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $15.5 million in 2021, then soared by 43.85% to $22.2 million in 2022, then skyrocketed by 56.43% to $34.8 million in 2023, then increased by 21.1% to $42.1 million in 2024, then crashed by 107.47% to -$3.1 million in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Other Gross PP&E Adjustments are -$3.1 million (Q3 2025), -$3.2 million (Q2 2025), and -$3.2 million (Q1 2025).